Search the GHTC website

Global health R&D delivers for Massachusetts

US government investment in global health R&D has delivered

$731.1 million
to Massachusetts research institutions
8,400+ new jobs
for Massachusetts
Global health R&D at work in Massachusetts

Researchers from Harvard Medical School, Partners In Health, and Boston Children’s Hospital have shown that a new commercially developed rapid test for Ebola, performed at the point of care, was as effective as a conventional laboratory-based method. The successful field trial is a potential gamechanger. A test that can accurately diagnose Ebola within minutes provides clinicians with crucial information for treating patients and containing outbreaks.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: USAID